Sign in
4

Changes in Ownership

XBiotech Inc. Filed Acc 0001209191-19-039527

Options or other derivatives

  • Chief Executive Officer acquired 300,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SIMARD JOHN · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-06-27 Exercise or conversion : show line 1 in the form Stock Option +300,000 $7.45 $2,235,000 300,000 D
Loading xslF345X03/doc4.xml…